ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Prepares To Dispense A Torrent Of New Money For Cancer Research.

March 6, 2009

CCOPs Payline Set In Low 220s Fr Now; 45 To Be Funded

May 15, 1987

O’Leary Leads RPCI’s OR;

February 8, 2002

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981